4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-20-018225
CFO and Country Manager acquired 77,351 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hadar Ilan · CFO and Country Manager
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-09 | Grant or award : show line 1 in the form | +8,339 | 8,339 | D |
| 2020-03-09 | Grant or award : show line 2 in the form | +69,012 | 77,351 | D |
Table II: Derivative
10 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-03-09 | Grant or award : show line 3 in the form Stock Options | +3,239 | $3.25 | 2024-03-31 | 3,239 | 3,239 | D |
| 2020-03-09 | Grant or award : show line 4 in the form Stock Options | +14,291 | $9.22 | 2024-11-19 | 14,291 | 14,291 | D |
| 2020-03-09 | Grant or award : show line 5 in the form Stock Options | +10,663 | $11.43 | 2025-01-15 | 10,663 | 10,663 | D |
| 2020-03-09 | Grant or award : show line 6 in the form Stock Options | +119,667 | $12.04 | 2025-11-10 | 119,667 | 119,667 | D |
| 2020-03-09 | Grant or award : show line 7 in the form Stock Options | +35,544 | $10.70 | 2026-03-01 | 35,544 | 35,544 | D |
| 2020-03-09 | Grant or award : show line 8 in the form Stock Options | +35,774 | $17.40 | 2027-01-01 | 35,774 | 35,774 | D |
| 2020-03-09 | Grant or award : show line 9 in the form Stock Options | +116,231 | $8.81 | 2027-08-08 | 116,231 | 116,231 | D |
| 2020-03-09 | Grant or award : show line 10 in the form Stock Options | +20,789 | $10.81 | 2028-02-27 | 20,789 | 20,789 | D |
| 2020-03-09 | Grant or award : show line 11 in the form Stock Options | +56,275 | $6.44 | 2029-01-01 | 56,275 | 56,275 | D |
| 2020-03-09 | Grant or award : show line 12 in the form Stock Options | +57,086 | $6.81 | 2030-02-24 | 57,086 | 57,086 | D |
Loading xslF345X03/doc4.xml…